Use of microbore LC-MS/MS for the quantification of oxcarbazepine and its active metabolite in rat brain microdialysis samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 831, Issue 1-2, 2006, Pages 205-212

  Lanckmans, Katrien ^a   Clinckers, Ralph ^a   Van Eeckhaut, Ann ^a   Sarre, Sophie ^a   Smolders, Ilse ^a   Michotte, Yvette ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

10,11 Dihydro 10 hydroxycarbamazepine; Column switching; Microbore LC MS MS; Oxcarbazepine; Rat brain microdialysis

Indexed keywords

BIOASSAY; BIODIVERSITY; CALIBRATION; DIALYSIS; METABOLITES; ORGANIC ACIDS;

10,11-DIHYDRO-10-HYDROXYCARBAMAZEPINE; COLUMN SWITCHING; MICROBORE LC-MS/MS; OXCARBAZEPINE; RAT BRAIN MICRODIALYSIS;

BRAIN;

2 METHYL 5H DIBENZ(B,F)AZEPINE 5 CARBOXAMIDE; ANTICONVULSIVE AGENT; DRUG METABOLITE; FORMIC ACID; LICARBAZEPINE; OXCARBAZEPINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BRAIN; CALIBRATION; CONTROLLED STUDY; DIALYSATE; DRUG STRUCTURE; ELECTROSPRAY; EXTRACELLULAR SPACE; HIPPOCAMPUS; LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEPARATION TECHNIQUE;

ANIMALS; BRAIN CHEMISTRY; CARBAMAZEPINE; CHROMATOGRAPHY, LIQUID; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; MICRODIALYSIS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

ANIMALIA;

EID: 31544447765     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2005.12.003     Document Type: Article

References (17)

1. A. Tracy, and M.D. Glauser Pharmacotherapy 21 2001 904
2. K. Van Belle, S. Sarre, G. Ebinger, and Y. Michotte Eur. J. Pharm. Sci. 3 1995 273
3. H. Levert, P. Odou, and H. Robert J. Pharm. Biomed. Anal. 28 2002 517
4. F. Bugamelli, C. Sabbioni, R. Mandrioli, E. Kenndler, F. Albani, and M.A. Raggi Anal. Chim. Acta 472 2002 1
5. R. Mandrioli, N. Ghedini, F. Albani, E. Kenndler, and M.A. Raggi J. Chromatogr. B 783 2003 253
6. G. Flesch, D. Tudor, J. Denouel, J. Bonner, and R. Camisasca Int. J. Clin. Parmacol. Ther. 41 2003 299
7. R. Hartley, M. Green, M.D. Lucock, S. Ryan, and W.I. Forsythe Biomed. Chromatogr. 5 1991 212
8. H.H. Maurer, C. Kratzsch, A.A. Weber, F.T. Peters, and T. Kraemer J. Mass Spectrom. 37 2002 687
9. K. Van Belle, I. Verfaillie, G. Ebinger, and Y. Michotte J. Chromatogr. B 672 1995 97
10. C.L. Nilsson, G. Karlsson, J. Bergquist, A. Westman, and R. Ekman Peptides 19 1998 781
11. R. Clinckers, I. Smolders, A. Meurs, G. Ebinger, and Y. Michotte Neuropharmacology 47 2004 1053
12. R. Clinckers, I. Smolders, A. Meurs, G. Ebinger, and Y. Michotte J. Neurochem. 89 2004 834
13. N. Kishi, N. Mano, and N. Asakawa Anal. Sci. 17 2001 709
14. F. Giorgianni, A. Cappiello, S. Beranova-Giorgianni, P. Palma, H. Trufelli, and D.M. Desiderio Anal. Chem. 76 2004 7028
15. M.C. Garcia, A.C. Hogenboom, H. Zappey, and H. Irth J. Chromatogr. A 957 2002 187
16. V.P. Shah, K.K. Midha, S. Dighe, I. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, R.D. McDowall, and K.A. Pittman Eur. J. Drug Metab. Pharmacokinet. 16 1991 249
17. EMEA, ICH Topic Q 2 B (1996).